129 related articles for article (PubMed ID: 30055381)
1. Validation in SPECT imaging on presynaptic dopaminergic deficit for dementia with Lewy bodies and degenerative Parkinsonism.
Kawada T
J Neurol Sci; 2018 Sep; 392():116. PubMed ID: 30055381
[No Abstract] [Full Text] [Related]
2. Scan without evidence of dopaminergic deficit (SWEDD) in degenerative parkinsonism and dementia with Lewy bodies: A prospective study.
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Feb; 385():17-21. PubMed ID: 29406901
[TBL] [Abstract][Full Text] [Related]
3. Progression of dopaminergic degeneration in dementia with Lewy bodies and Parkinson's disease with and without dementia assessed using 123I-FP-CIT SPECT.
Colloby SJ; Williams ED; Burn DJ; Lloyd JJ; McKeith IG; O'Brien JT
Eur J Nucl Med Mol Imaging; 2005 Oct; 32(10):1176-85. PubMed ID: 15931516
[TBL] [Abstract][Full Text] [Related]
4. [The applicability of 123I-FP-CIT SPECT dopamine transporter imaging in clinical practice].
Perlaki G; Szekeres S; Janszky J; Dezső D; Aschermann Z; Zámbó K; Kovács N
Ideggyogy Sz; 2019 Nov; 72(11-12):381-388. PubMed ID: 31834681
[TBL] [Abstract][Full Text] [Related]
5. Combined
Nicastro N; Burkhard PR; Garibotto V
J Neurol Sci; 2018 Sep; 392():126-127. PubMed ID: 30056199
[No Abstract] [Full Text] [Related]
6. Striatal dopamine transporter in dementia with Lewy bodies and Parkinson disease: a comparison.
Walker Z; Costa DC; Walker RW; Lee L; Livingston G; Jaros E; Perry R; McKeith I; Katona CL
Neurology; 2004 May; 62(9):1568-72. PubMed ID: 15136683
[TBL] [Abstract][Full Text] [Related]
7. Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies.
Walker RW; Walker Z
Mov Disord; 2009; 24 Suppl 2():S754-9. PubMed ID: 19877236
[TBL] [Abstract][Full Text] [Related]
8. Degeneration of nigrostriatal dopaminergic neurons in the early to intermediate stage of dementia with Lewy bodies and Parkinson's disease.
Okitsu M; Sugaya K; Nakata Y; Kawazoe T; Ikezawa J; Okiyama R; Takahashi K
J Neurol Sci; 2023 Jun; 449():120660. PubMed ID: 37084522
[TBL] [Abstract][Full Text] [Related]
9. Iodine-123 metaiodobenzylguanidine scintigraphy and iodine-123 ioflupane single photon emission computed tomography in Lewy body diseases: complementary or alternative techniques?
Treglia G; Cason E; Cortelli P; Gabellini A; Liguori R; Bagnato A; Giordano A; Fagioli G
J Neuroimaging; 2014; 24(2):149-54. PubMed ID: 23163913
[TBL] [Abstract][Full Text] [Related]
10. Scan without evidence of dopaminergic deficit: A 10-year retrospective study.
Nicastro N; Garibotto V; Badoud S; Burkhard PR
Parkinsonism Relat Disord; 2016 Oct; 31():53-58. PubMed ID: 27421952
[TBL] [Abstract][Full Text] [Related]
11. The usefulness of combined brain perfusion single-photon emission computed tomography, Dopamine-transporter single-photon emission computed tomography, and
Kobayashi S; Makino K; Hatakeyama S; Ishii T; Tateno M; Iwamoto T; Tsujino H; Kawasaki K; Mikuni K; Ukai W; Murayama T; Hashimoto E; Utsumi K; Kawanishi C
Psychogeriatrics; 2017 Jul; 17(4):247-255. PubMed ID: 28130808
[TBL] [Abstract][Full Text] [Related]
12. Severity of neuropsychiatric symptoms and dopamine transporter levels in dementia with Lewy bodies: a 123I-FP-CIT SPECT study.
Roselli F; Pisciotta NM; Perneczky R; Pennelli M; Aniello MS; De Caro MF; Ferrannini E; Tartaglione B; Defazio G; Rubini G; Livrea P
Mov Disord; 2009 Oct; 24(14):2097-103. PubMed ID: 19705471
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of brain perfusion SPECT using an easy Z-score imaging system (eZIS) as an adjunct to early-diagnosis of neurodegenerative diseases.
Waragai M; Yamada T; Matsuda H
J Neurol Sci; 2007 Sep; 260(1-2):57-64. PubMed ID: 17493637
[TBL] [Abstract][Full Text] [Related]
14. Impact of 123I-FP-CIT (DaTSCAN) SPECT on the diagnosis and management of patients with dementia with Lewy bodies: a retrospective study.
Kemp PM; Clyde K; Holmes C
Nucl Med Commun; 2011 Apr; 32(4):298-302. PubMed ID: 21278615
[TBL] [Abstract][Full Text] [Related]
15. Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies.
Siepel FJ; Dalen I; Grüner R; Booij J; Brønnick KS; Buter TC; Aarsland D
Mov Disord; 2016 Jan; 31(1):118-25. PubMed ID: 26207978
[TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies.
O'Brien JT; Colloby S; Fenwick J; Williams ED; Firbank M; Burn D; Aarsland D; McKeith IG
Arch Neurol; 2004 Jun; 61(6):919-25. PubMed ID: 15210531
[TBL] [Abstract][Full Text] [Related]
17. The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration.
Cummings JL; Henchcliffe C; Schaier S; Simuni T; Waxman A; Kemp P
Brain; 2011 Nov; 134(Pt 11):3146-66. PubMed ID: 21810889
[TBL] [Abstract][Full Text] [Related]
18. Role of dopamine transporter imaging in routine clinical practice.
Marshall V; Grosset D
Mov Disord; 2003 Dec; 18(12):1415-23. PubMed ID: 14673877
[TBL] [Abstract][Full Text] [Related]
19. Dopaminergic imaging in degenerative parkinsonisms, an established clinical diagnostic tool.
Nicastro N; Nencha U; Burkhard PR; Garibotto V
J Neurochem; 2023 Feb; 164(3):346-363. PubMed ID: 34935143
[TBL] [Abstract][Full Text] [Related]
20. Dementia with Lewy bodies versus Alzheimer's disease: role of dopamine transporter imaging.
Costa DC; Walker Z; Walker RW; Fontes FR
Mov Disord; 2003 Oct; 18 Suppl 7():S34-8. PubMed ID: 14531044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
